Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S Baluch

Showing results (1-10 of 9) with videos related to

Pageof 1
Sort By:
Clinical Oncology (Royal College of Radiologists (Great Britain))|June 16, 2015
The Quality of Curative-intent Radiotherapy for Non-small Cell Lung Cancer in the UKJ McAleese, S Baluch, K Drinkwater
Clinical Oncology (Royal College of Radiologists (Great Britain))|September 15, 2022
Assessment of the Implementation of Lung Cancer Consensus Statements From the Royal College of Radiologists in 2021; Progress and BarriersJ McAleese, K Tumelty, S Baluch, et al.
Annals of the New York Academy of Sciences|February 21, 2004
Molecular electronics on silicon: an ultrahigh vacuum scanning tunneling microscopy studyNathan P Guisinger, Rajiv Basu, Andrew S Baluch, et al.
Clinical Oncology (Royal College of Radiologists (Great Britain))|July 25, 2017
The Elderly are Less Likely to Receive Recommended Radical Radiotherapy for Non-small Cell Lung CancerJ McAleese, S Baluch, K Drinkwater, et al.
British Journal of Cancer|June 1, 1991
Monitoring therapeutic response to tamoxifen in NMU-induced rat mammary tumours by 31P MRSS Baluch, C J Midwood, J R Griffiths, et al.
Clinical Oncology (Royal College of Radiologists (Great Britain))|August 31, 2019
Curative Radiotherapy for Lung Cancer in the UK: International BenchmarkingJ McAleese, C M Rooney, S Baluch, et al.
NMR in Biomedicine|July 1, 1993
Pattern recognition of 31P magnetic resonance spectroscopy tumour spectra obtained in vivoS L Howells, R J Maxwell, F A Howe, et al.
NMR in Biomedicine|May 1, 1993
The effect of oestrogen ablation on the phospholipid metabolite content of primary and transplanted rat mammary tumoursT A Smith, S Baluch, J C Titley, et al.
Leukemia|June 18, 2004
Efficacy of dual-specific Bcr-Abl and Src-family kinase inhibitors in cells sensitive and resistant to imatinib mesylateA J Tipping, S Baluch, D J Barnes, et al.
Pageof 1

Showing results (1-10 of 9) with videos related to

Sort By:
Pageof 1
Clinical Oncology (Royal College of Radiologists (Great Britain))|June 16, 2015
The Quality of Curative-intent Radiotherapy for Non-small Cell Lung Cancer in the UKJ McAleese, S Baluch, K Drinkwater
Clinical Oncology (Royal College of Radiologists (Great Britain))|September 15, 2022
Assessment of the Implementation of Lung Cancer Consensus Statements From the Royal College of Radiologists in 2021; Progress and BarriersJ McAleese, K Tumelty, S Baluch, et al.
Annals of the New York Academy of Sciences|February 21, 2004
Molecular electronics on silicon: an ultrahigh vacuum scanning tunneling microscopy studyNathan P Guisinger, Rajiv Basu, Andrew S Baluch, et al.
Clinical Oncology (Royal College of Radiologists (Great Britain))|July 25, 2017
The Elderly are Less Likely to Receive Recommended Radical Radiotherapy for Non-small Cell Lung CancerJ McAleese, S Baluch, K Drinkwater, et al.
British Journal of Cancer|June 1, 1991
Monitoring therapeutic response to tamoxifen in NMU-induced rat mammary tumours by 31P MRSS Baluch, C J Midwood, J R Griffiths, et al.
Clinical Oncology (Royal College of Radiologists (Great Britain))|August 31, 2019
Curative Radiotherapy for Lung Cancer in the UK: International BenchmarkingJ McAleese, C M Rooney, S Baluch, et al.
NMR in Biomedicine|July 1, 1993
Pattern recognition of 31P magnetic resonance spectroscopy tumour spectra obtained in vivoS L Howells, R J Maxwell, F A Howe, et al.
NMR in Biomedicine|May 1, 1993
The effect of oestrogen ablation on the phospholipid metabolite content of primary and transplanted rat mammary tumoursT A Smith, S Baluch, J C Titley, et al.
Leukemia|June 18, 2004
Efficacy of dual-specific Bcr-Abl and Src-family kinase inhibitors in cells sensitive and resistant to imatinib mesylateA J Tipping, S Baluch, D J Barnes, et al.
Pageof 1